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Introduction 
Onychomycosis is the fungal infection of the nail [1, 
2]. It is the most frequently occurring nail disease 
with an incidence of 2-13% in the general population 
but increasing to 48% by age seventy [3]. The most 
common pathogens implicated in onychomycosis 
are a class of keratin metabolizing organisms 
designated as the dermatophytes [4, 5] of which the 
most prevalent are Trichophyton rubrum and 
Trichophyton mentagrophytes. These two alone 
account for the majority of all documented 
onychomycosis cases [2, 6, 7]. Other fungal 
pathogens are also reported as a cause of 
onychomycosis and include various saprophytic 
molds as well as yeasts [8-11].  
Traditionally onychomycosis has been diagnosed by 
either direct microscopy (KOH preparation) or by 
fungal culture. Although historically popular, each of 
these methods has been found to not accurately 
detect a significant number of cases [3, 12-16]. Newer 
techniques such as histologic staining and PCR offer 
better performance. For histopathology, formalin-
fixed paraffin-embedded sections are subjected to 
periodic acid-Schiff (PAS) reaction, [17, 18] and/or 
staining with Gomori methenamine silver, [18, 19] 
and examined microscopically for the presence of 
fungal elements. Although offering excellent 
sensitivity, histopathology requires a longer 
turnaround time than direct KOH microscopy or PCR 
and is unable to identify the genus or species of the 
infecting agent. 
PCR testing has the capability of offering faster 
turnaround times, as well as improved sensitivity and 
specificity over other methods [7, 12, 13]. Further, 
PCR is able to also identify the genus and species of 
the infecting organism(s) [14, 20]. Sensitive detection 
coupled with fungal identification is beneficial when 
making decisions associated with anti-fungal 
Abstract 
Onychomycosis is a prevalent disease of the nail. 
Traditional methods for diagnosis include direct 
microscopy with potassium hydroxide (KOH 
microscopy) and fungal culture. Other techniques 
using histochemical staining have higher sensitivity, 
but cannot identify genus or species of the infecting 
agent. PCR assays are sensitive, specific, and capable 
of genus and species level identification. We describe 
a real-time PCR assay for 15 different fungi that are 
associated with onychomycosis. Of 425 clinical 
samples suspected of onychomycosis analyzed by 
fungal culture and PCR, 219 samples were positive for 
both (52% agreement). Of the 206 discordant 
samples, 95% were resolved in favor of PCR by DNA 
sequencing. On a larger data set of 2,452 samples, 
positivity rates for histopathology, PCR, and culture 
were 85%, 73%, and 54% respectively. Further, 48% 
of PCR positive and 51% of histopathology positive 
samples were negative by culture. PCR outperformed 
culture compared to histopathology for sensitivity 
(80% versus 49%), specificity (92% versus 79%), 
positive predictive value (94% versus 77%), and 
negative predictive value (76% versus 52%). These 
results indicate the culture method lacks the 
sensitivity to be a reliable assay for onychomycosis, 
that PCR and histopathology are highly concordant, 
and that PCR provides the highest degree of 
diagnostic accuracy available. 
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therapy [21-23]. For these reasons, molecular tests 
are increasingly used for the improved clinical 
diagnosis of onychomycosis [15]. 
Our laboratory now performs histological staining, 
PCR, and culture for onychomycosis diagnosis, and 
has accumulated data for a large number of nail 
samples collected from geographically dispersed 
patients suspected of having onychomycosis. These 
data were used to compare culture, histopathology 
and PCR methods. 
 
Methods 
Sample collection 
Nail samples from suspected cases of 
onychomycosis were collected by podiatrists in the 
normal course of their patient care and submitted to 
Bako Diagnostics for clinical laboratory testing. 
Samples were collected as dry keratin tissue and 
include distal nail clippings and scrapings and 
shipped dry. Minimum requirements for PCR testing 
were 0.3cm2 of specimen. Samples were aseptically 
minced and thereafter portions submitted to 
histopathology for embedding and staining, to the 
molecular department for DNA isolation and PCR 
testing, and to microbiology for fungal culture. All 
samples used for the studies described here were 
tested with histopathology, culture, and PCR. 
Microbial Culture 
Upon receipt at the laboratory, the nail samples were 
inoculated onto potato dextrose and mycobiotic 
agars [24]. All work was performed in a biosafety 
cabinet. Inoculated plates were wrapped in parafilm 
and then incubated at 31.8° C. The cultures were 
visually inspected for fungal growth at days 3, 7, 14, 
21, and 28. Fungi were identified by mass 
spectroscopy (bioMerieux MALDITOF). Fungi not 
identified by mass spectrometry were identified 
microscopically using lacto-phenol aniline blue stain 
(Remel, San Diego, CA). 
PCR  
Clinical nail samples were first subjected to bead 
beating followed by incubation at 56C in a 
Proteinase K lysis buffer for 30 minutes (Omega 
Biotek, Norcross, GA). DNA was thereafter purified 
from crude extracts using a magnetic bead 
purification procedure with the Mag-Bind Plant 
Double Stranded DNA kit (Omega Biotek, Norcross, 
GA) automated on the Hamilton MicroLab STAR 
workstation. The extracted sample material was then 
used for the PCR screening test and/or one or more 
PCR reflex tests.  
The PCR assays described here can detect up to 15 
different fungi associated with onychomycosis. The 
test consists of distinct steps, the first being a 
screening test to determine the presence or absence 
of one or more of three types of fungi — 
dermatophytes, saprophytes, and yeast. No specific 
genus or species identification is determined at this 
stage. This screening test is designed to screen out 
negative samples and/or identify those samples that 
require further analysis to identify the causative 
agent(s). In the event a positive result is obtained for 
one or more fungal types, specific reflex test(s) are 
performed to determine the genus and/or species of 
fungi present in the nail (Figure 1). 
PCR screening tests were assembled on a Hamilton 
Starlet workstation in 384-well format with specific 
primer sets and SYBR Green reaction mix 
(ThermoFisher, Waltham, MA) and then analyzed on 
the QuantStudio 6 real time PCR machine 
(ThermoFisher, Waltham, MA) using real time PCR 
and melt curve analysis. Positive screen test samples 
were then analyzed as above using primer sets 
specific for the indicated reflex test and SYBR green 
reaction mix on the ABI 7500 (ThermoFisher, 
Waltham, MA). Gene targets include ribosomal RNA 
Screen Test Reflex Tests 
Figure 1.  Description of two-step fungal PCR Assay. Screen 
Panel.  Nail samples suspected of onychomycosis are discretely 
screened for the presence or absence of three classes of fungi. 
Reflex Panels. Nail samples that have a positive Screen Test for 
one or more classes of fungi will have the sample run with the 
corresponding Reflex Test(s).  
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gene and mitochondrial gene regions of the fungal 
genomes designed to detect fungal classes (screen 
test) and other specific molecular targets to identify 
the genus/species of the disease-causing agent 
(reflex tests). Raw data in the form of Ct and Tm 
values were auto analyzed by an internally 
developed PCR Analysis Engine designed to assign 
results compared to validated Ct cutoff and Tm 
ranges for each target, and followed by manual 
review of results before release.  
DNA Sequencing 
Forward and reverse primers were designed in 
fungal consensus regions in the 18S rRNA gene to 
generate amplicons ~485 bp in length. PCR 
amplification was performed using GeneAmp® Fast 
PCR Master Mix (2×), (ThermoFisher, Waltham, MA). 
Amplification was performed on the 7500 Fast Real-
Time PCR System (ThermoFisher, Waltham, MA) and 
confirmed by gel electrophoresis analysis with the 
FlashGel™ system, 1.2% agarose (Lonza Rockland, 
Inc, Rockland, ME). Amplicons were purified using 
the QIAquick 96 PCR Purification Kit (Qiagen, Hilden, 
DE) and eluted into Molecular Grade Water. 
Sequencing of purified amplicons was performed by 
the Georgia Genomics Facility (University of Georgia, 
Athens, GA). Raw data files were retrieved for 
analysis. Forward and reverse sequences were 
aligned and assembled by Geneious 7.1.6 software 
(Biomatters Ltd, Auckland, NZ) using the de novo 
assembly function. Resulting sequences were 
analyzed using BLAST for genera identification. 
Histopathology Staining 
PAS staining was conducted on tissue sections using 
an automated process on the Sakura Linear stainer 
(Sakura Finetech, Torrance, CA). Briefly slides were 
immersed in xylene to remove paraffin and then 
rehydrated by successive rinses in 100% alcohol 
followed by 95% alcohol and then a water rinse. They 
were then oxidized in 1% periodic acid for 13 
minutes, rinsed with tap water and stained with 
Schiff reagent for 20 minutes. Following another 
water rinse, the slides were counter-stained with 
hematoxylin for 50 seconds, rinsed in water, and 
treated in Define solution as a clarifying agent for 20 
seconds. After another water rinse, the procedure 
was completed by several washes in 95% and 100% 
alcohol and then xylene to dehydrate and mount.  
Gomori methenamine silver staining is conducted on 
tissue sections using an automated process on the 
Prisma Stainer (Sakura Finetech, Torrance, CA). 
Briefly, slides are immersed in xylene to remove 
paraffin and then rehydrated by successive rinses in 
100% alcohol followed by 95% alcohol and a water 
rinse. They are then oxidized in 7% chromic acid 
solution for 10 minutes, followed by a 4-minute 
water rinse. Slides are next rinsed in 1% sodium 
bisulfate and rinsed in water before being treated in 
a 0.1% gold chloride solution for three minutes to 
enhance staining. Water rinses and a 5% sodium 
thiosulfate rinse to remove excess silver nitrate 
proceeds counter staining in Light Green solution for 
three minutes. Water rinses and washes in 100% 
alcohol and xylene for dehydration before mounting 
completes the staining procedure. 
Data comparison and calculations: 
The culture, histopathology and PCR methods were 
compared to each other with accuracy, sensitivity, 
specificity, and predictive values of both positive and 
negative results calculated. Analyses were formatted 
and calculated as defined in Table 1. 
 
Table 1. Data Analysis Format and Definitions. 
  Comparator Method  
  Positive Negative 
Reference 
Standard 
Positive True Positive (TN) 
False 
Negative (FN)
Negative False Positive (FP) 
True 
Negative (TN)
Accuracy- the overall agreement between two methods = 
(TP+TN)/(TP+FP+FN+TN). 
Sensitivity- proportion of patients with the disease who test 
positive = TP/(TP+FN). 
Specificity- proportion of patients without the disease who test 
negative = TN/(TN+FP). 
Positive Predictive Value (PPV)- proportion of patient with positive 
results who have the disease = TP/(TP+FP). 
Negative Predictive Value (NPV)- proportion of patients with 
negative results who do not have the disease = TN/(TN+FN). 
Reference Standard- the method that is being used as the source of 
the “correct” result. 
Comparator method- the method that is being compared to the 
reference standard and has its performance described by accuracy, 
sensitivity, specificity, PPV and NPV. 
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Results 
An initial validation set of the PCR test’s performance 
used 425 clinical samples submitted for fungal 
culture. Table 2 shows the distribution of the 425 
results with respect to dermatophyte, saprophyte, 
yeast and negative results obtained with the two 
methods. Culture positive samples were observed 
for 203 samples (48%) with 68 (16%) of the total 
reported as dermatophyte, 97 (23%) reported as 
saprophytes, and 38 (9%) as yeast. For the same 425 
samples, 284 (67%) were positive by PCR with 198 
(47%) of the total reported as dermatophyte, 50 
(12%) as saprophyte, and 36 (8%) as yeast. A total of 
206 discordant results between the culture and PCR 
methods were observed for an overall concordance 
of 52% (219/425). 
Sufficient sample quantities allowed 172 of the total 
206 discordant samples to be tested further by 
sequencing of a 485 base pair region of the fungal 
18S ribosomal RNA gene. Results show that 167 
samples (97.1%) resolved in favor of the original PCR 
assay result whereas only four samples (2.3%) 
resolved in favor of the original culture result. One 
sample (0.6%) resolved in favor of neither method 
(Table 3). Notably, of the original 139 samples that 
were dermatophyte negative by culture but 
dermatophyte PCR positive, 134 (96%) were positive 
for a dermatophyte by sequencing. This included 41 
dermatophyte PCR positive samples that grew only 
saprophytes on culture. Eleven other saprophyte-
positive cultures that were saprophyte PCR negative 
were also sequenced. Ten of these were negative by 
sequencing suggesting the saprophyte reported was 
a contaminant. It is also possible that the cultured 
saprophytes present were valid, but not recognized 
by the different primer sets used for either the PCR 
assay or DNA sequencing. However, during 
validation of the assay, multiple strains of off target 
organisms were tested to verify specificity. This and 
the broad nature of the saprophyte PCR screen 
makes this scenario of unrecognized saprophytes 
unlikely. Lastly, of the 15 culture positive yeast 
samples that were sequenced, 7 sequenced as a 
dermatophyte and four were negative by 
sequencing, which confirmed the prior PCR results. 
As a control for the sequencing method, 36 of 219 
concordant samples were sequenced and gave the 
same result as originally reported by the two 
methods. The results of PCR compared to culture 
following discordant resolution by sequencing 
(Table 4) show a concordance of 91% (385/425).  
A large sequentially selected clinical sample set of 
2,452 samples was selected for assessment as each 
was tested by culture, histopathology, and PCR. Of 
the 2,452 samples, 1,707 (70%) tested positive by at 
least one of the methods and 745 (30%) tested 
Table 3.  Sequencing results of discordant samples between 
fungal culture and PCR methods. 
Sequence 
Result 
Culture 
agree PCR Agree 
Neither 
agree 
Yeast  3 
Dermatophyte 3 134 
Saprophyte 1 13 1 
Negative  17 
Total 4 167 1 
% 2.3 97.1 0.6 
Table 2. Result distribution of culture and PCR methods for 425 nail samples. 
  Fungal Culture  
 Result Yeast Dermatophyte Saprophyte Negative Total % 
PCR 
Yeast 26 (4) 1 3 6 (4) 36 8% 
Dermatophyte 7 (7) 59 (15) 43 (41) 89 (86) 198 47% 
Saprophyte 0 1 28 (1) 21 (13) 50 12% 
Negative 5 (4) 7 (6) 23 (11) 106 (16) 141 33% 
 Total 38 68 97 222 425 
 % 9% 16% 23% 52% 
Parentheses indicate samples that were subjected to DNA sequencing. 
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negative by all three methods (Table 5A). Of the 
1,707 positive samples as the denominator, 
histopathology detected fungi in 85%, PCR in 73% 
and culture in 54%, respectively (Table 5B), similar to 
the positivity rate observed in the 425-sample data 
set that compared PCR to culture (Table 2). 
Table 6 indicates that PCR matches with 
histopathology much more closely than culture in all 
aspects including accuracy (85% versus 61%), 
sensitivity (80% versus 49%), specificity (92% versus 
79%), positive predictive value (94% versus 77%), 
and negative predictive value (76% versus 52%). 
Discussion 
The purpose of this study was to compare our fungal 
PCR assay to fungal culture and histopathology 
staining for the diagnosis of onychomycosis. 
Onychomycosis constitutes an important public 
health problem owing to its high incidence, 
increasing prevalence, and associated complications 
[1, 5, 25, 26] Persons with onychomycosis have been 
shown to be at increased risk to develop cellulitis and 
skin ulcerations, both of which may lead to loss of 
digits or limb [1, 26, 27]. In addition to advanced age 
and immunological deficiencies, additional 
predisposing factors are chronic microtrauma to the 
nail apparatus, onycholysis, onychoschizia, and 
genetic predisposing factors [5]. 
In current practice, direct KOH microscopy and 
fungal culture are most widely used to diagnose 
onychomycosis. Direct KOH microscopy of nails is 
generally performed in 10-20% KOH solution 
followed by examination under a microscope for 
fungal elements. Direct KOH microscopy is a rapid 
and economical method, but can lack sensitivity, 
with false negative results of 5% to 15% versus fungal 
Table 5 A. Distribution of test results from three diagnostic 
methods on 2452 nail samples suspected of onychomycosis.  
No. 
Samples Culture PCR Histology 
% Samples 
tested
745 - - - 30% 
609 + + + 25% 
550 - + + 22% 
189 - - + 8% 
179 + - - 7% 
101 + - + 4% 
50 - + - 2% 
29 + + - 1% 
1707 Any Method Positive 70% 
745 Negative 30% 
2452 Total 100% 
 
B.  Sensitivity for each method. 
No. Method %  
1449 Histology Positive 85% 
1238 PCR Positive 73% 
918 Culture Positive 54% 
Table 6.  PCR and culture performance compared to 
histopathology as the reference method on 2452 samples 
assayed with all three methods.  
Culture + Culture - PCR+ PCR- 
Histology + 710 739 1159 290 
Histology - 208 795 79 924 
Accuracy 61% 85% 
Sensitivity 49% 80% 
Specificity 79% 92% 
PPV 77% 94% 
NPV 52% 76% 
Table 4. Result distribution of culture and PCR methods on 425 nail samples with sequencing to resolve discordant samples. 
  Culture + Sequencing  
   Yeast Dermatophyte Saprophyte Negative Total 
PC
R 
+ 
Se
q 
Yeast 29 1 3 4 37 9% 
Dermatophyte 0 192 3 3 198 47% 
Saprophyte 0 1 42 7 50 12% 
Negative 1 4 13 122 140 33% 
 Total 30 198 61 136 425 
   7% 47% 14% 32% 
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culture [3, 15, 16]. This method is non-specific in that 
it cannot differentiate between dermatophytes and 
other fungal species [3, 28, 29]. Recent articles have 
reported that in the diagnosis of onychomycosis, 
direct KOH microscopy sensitivity is 64% compared 
to fungal culture or a combination of direct KOH, 
fungal culture, and PAS staining [28, 30]. A dye such 
as calcofluor white may be used to help with the 
visualization, which may increase sensitivity [31]. 
Fungal culture has historically been the de facto 
reference standard for onychomycosis. Two big 
drawbacks are the long turnaround time required for 
test results, which can be several weeks, and its 
broadly reported poor sensitivity. Recent articles 
have claimed that in the diagnosis of 
onychomycosis, fungal culture sensitivity ranged 
from 30%-57% [2, 15, 16, 28-30]. Hypotheses to 
explain these observations include dead organisms 
that will not grow in culture [3, 16, 25], inaccessibility 
of the organism trapped in nail keratin to the growth 
media [3, 14], prior treatment with anti-fungal agents 
that inhibit culture growth [12, 14-16], sampling error 
[14, 20], and the slow growth of dermatophytes in 
culture [32].  
For these reasons, the use of fungal culture for 
onychomycosis diagnosis has been criticized. 
Spiliopoulou et al. [14] reported that out of 418 
samples from patients suspected of onychomycosis 
over a 3-year period, 10.5% were positive for 
dermatophytes using culture, whereas three times as 
many, 30.1%, were positive for dermatophytes by a 
commercial dermatophyte PCR assay. Mehlig et al. 
[12] reported that out of 253 patients tested for 
onychomycosis 34.4% were positive by KOH direct 
microscopy, 31.6% by culture, and 50.6% by a 
commercial multiplex PCR test. In another report 
Dhib et al. [13] reported that 91.3% of culture 
negative specimens were PCR positive in their study. 
There are many other reports documenting the poor 
culture sensitivity [2, 3, 15, 16, 20, 29, 33-38]. 
Our current results comparing 425 results of PCR to 
fungal culture indicated 48% were culture positive 
and 67% were PCR positive, both in line with the 
literature. Although the poor sensitivity of fungal 
culture is evident in our data, its inability to detect a 
significant number of dermatophytes is concerning. 
Dermatophytes are difficult to culture as they are 
slow growing. Their growth can be inhibited by 
saprophytic molds that can overgrow the culture 
and obscure slower growing dermatophytes [13-16, 
20, 29]. Our results demonstrate that 41 of 97 (42%) 
of cultures reported to be positive for saprophytes 
and negative for dermatophytes were identified as 
positive for dermatophytes as detected by PCR and 
confirmed by DNA sequencing. This is similar to that 
reported by Wisselink et al. [39] who found that 24% 
of cultures with mold detected dermatophyte DNA 
by PCR. When DNA sequencing was used to resolve 
the disparities in our data between culture and PCR, 
PCR results were typically supported by DNA 
sequencing. A similar conclusion was drawn by Sato 
et al. [38] when comparing a PCR microarray 
combination to culture results for onychomycosis. 
When discrepancies were sequenced, it was the PCR 
method that was found to be correct. 
Histologic staining of formalin-fixed paraffin-
embedded nail biopsy sections stained with PAS [17, 
18] and/or Gomori methenamine silver has proven to 
be quite useful in diagnosing onychomycosis, 
although there are differing opinions on the 
superiority of PAS versus Gomori methenamine 
silver stains for identifying fungal elements in nail 
samples [17, 19]. Our experience is that the two 
stains complement each other and help in the 
visualization of fungal structures. In addition, using 
histopathology staining, other information can be 
garnered such as direct visualization of fungal 
elements such as spores and hyphae, the degree of 
nail plate involvement, as well as the observation 
and identification of other primary and 
compounding causes of onychodystrophy. Of the 
two, PAS is the more widely used staining technique. 
Histopathology staining with PAS microscopy is 
significantly more sensitive than direct KOH 
microscopy or culture, with sensitivities ranging 
from 84-100% to diagnose onychomycosis [28, 30, 
36, 40, 41]. Drawbacks of PAS microscopy include 
higher cost, a longer turnaround time than direct 
KOH or PCR, and an inability to distinguish among 
fungal species. One recent study utilized a meta-
analysis methodology of 13 studies over a 16-year  
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period comparing over 2000 patient samples with 
direct KOH microscopy, culture, and histopathology. 
The study concluded that histopathology staining 
with PAS outperformed the other two techniques, 
but that combining tests with complementary 
attributes would establish the most accurate 
diagnosis [40]. 
PCR testing for onychomycosis adds the benefit of a 
fast turnaround time, good sensitivity and specificity, 
and the ability to identify organisms at the genus and 
species level [14, 20]. The fungal nail assay described 
here takes the approach of first screening nails 
suspected of onychomycosis for three types of fungi 
— dermatophytes, saprophytes, and yeast. As a 
substantial portion of nail samples submitted for 
analysis are negative for fungal elements, this 
screening approach can save time and cost for both 
the laboratory and the patient. Only in the event a 
screening test is positive, is reflex testing performed 
to identify the genus or species of the infecting 
organism. Together, the three reflex assays are 
capable of detecting 15 of the fungi most frequently 
associated with onychomycosis. Speciation or 
further identification of the pathogenic fungi is 
beneficial when making decisions associated with 
anti-fungal therapy as not all antifungal agents are 
effective against every fungus, and different 
treatment regimens may be indicated for different 
class or organisms [21, 23, 42-44]. Additionally, 
treatment for onychomycosis can be expensive and 
can require the use of oral antifungals that may 
produce side effects. For these reasons, the benefits 
of molecular tests for the clinical diagnosis of  
onychomycosis are becoming recognized [16].  
Our data indicates that either PCR or histopathology 
staining can offer better performance than fungal 
culture as both are more sensitive. It is evident from 
our data and others that no single method can be 
used as the ideal test for onychomycosis. It is now 
common to use combined methods as a diagnostic 
standard to take advantage of complementary 
performance characteristics and overcome 
limitations of any one method. A recent report 
indicates real-time PCR, combined with 
histopathology had the highest efficacy of any 
method or combination of methods tested for 
diagnosing onychomycosis [45]. Our study again 
indicates histopathology and the PCR test described 
have good concordance. 
 
Conclusion 
In conclusion, our data suggest that our fungal PCR 
assay has demonstrated superior sensitivity and 
specificity to fungal culture, with faster turnaround 
time in addition to the capability to determine fungal 
genus and species. Speciation of the pathogenic 
fungi is beneficial when making decisions associated 
with anti-fungal therapy as different organisms 
respond differently to various antifungal 
medications. In addition, the PCR assay is highly 
concordant with the results of the sensitive 
histopathology techniques that also identify acute 
and chronic trauma, neoplastic processes, and other 
non-infectious causes of onychodystrophy. 
Combined, PCR and histopathology provide the 
most comprehensive evaluation of nail unit 
dystrophy enabling the selection of appropriate 
treatment for the patient’s disease. By using these 
technologies in tandem, clinicians receive the 
highest sensitivity and specificity available for 
onychomycosis. 
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